Equities

Biodesix Inc

BDSX:NMQ

Biodesix Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.29
  • Today's Change0.085 / 7.08%
  • Shares traded437.52k
  • 1 Year change-13.76%
  • Beta1.1288
Data delayed at least 15 minutes, as of Nov 22 2024 20:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments264333
Total Receivables, Net7.685.073.66
Total Inventory------
Prepaid expenses------
Other current assets, total5.725.187.25
Total current assets405344
Property, plant & equipment, net308.824.18
Goodwill, net151515
Intangibles, net7.919.8012
Long term investments------
Note receivable - long term------
Other long term assets6.865.921.66
Total assets999376
LIABILITIES
Accounts payable2.931.691.66
Accrued expenses5.097.454.90
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.050.050.02
Other current liabilities, total251422
Total current liabilities332329
Total long term debt35259.99
Total debt352510
Deferred income tax------
Minority interest------
Other liabilities, total262417
Total liabilities957256
SHAREHOLDERS EQUITY
Common stock0.100.080.03
Additional paid-in capital424388322
Retained earnings (accumulated deficit)(420)(367)(302)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity4.582120
Total liabilities & shareholders' equity999376
Total common shares outstanding967831
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.